CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 37 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $73,000 | -29.8% | 3,976 | -30.1% | 0.00% | – |
| Q3 2020 | $104,000 | – | 5,692 | +94766.7% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 6 | -99.9% | 0.00% | – |
| Q3 2019 | $89,000 | -31.0% | 5,967 | -23.5% | 0.00% | – |
| Q2 2019 | $129,000 | +122.4% | 7,799 | +132.5% | 0.00% | – |
| Q1 2019 | $58,000 | -26.6% | 3,354 | -22.9% | 0.00% | – |
| Q3 2018 | $79,000 | +393.8% | 4,348 | +410.9% | 0.00% | – |
| Q2 2018 | $16,000 | -42.9% | 851 | -46.8% | 0.00% | – |
| Q1 2018 | $28,000 | +12.0% | 1,600 | -27.3% | 0.00% | – |
| Q4 2017 | $25,000 | -70.2% | 2,200 | -77.2% | 0.00% | – |
| Q2 2017 | $84,000 | – | 9,651 | +17133.9% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 56 | -61.4% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 145 | -4.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 151 | +196.1% | 0.00% | – |
| Q3 2015 | $1,000 | -85.7% | 51 | -72.9% | 0.00% | – |
| Q2 2015 | $7,000 | – | 188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|